Skip to content

Do the Cancer Cells Have Hormone Receptors?

Page last modified on: June 18, 2008

At a Glance

If your report just says "negative," ask your doctor or lab to give you a number. This is important because sometimes a low number may be called "negative." But even cancers with low numbers of receptors may respond to hormone therapy.

Hormone receptors are like ears on breast cells that listen to signals from hormones. These signals "turn on" growth in breast cells that have receptors.

A cancer is called "ER-positive" if it has receptors for the hormone estrogen. It is called "PR-positive" if it has receptors for the hormone progesterone. Breast cells that do not have receptors are "negative" for these hormones.

Breast cancers that are either ER-positive or PR-positive, or both, tend to respond well to hormone therapy.

These cancers can be treated with medicine that reduces the estrogen in your body. They can also be treated with medicine that keeps estrogen away from the receptors.

If the cancer has no hormone receptors, there are still very effective treatments available.

You will see the results of your hormone receptor test written in one of these three ways:

  • The number of cells that have receptors out of 100 cells tested. You will see a number between 0% (no receptors) and 100% (all have receptors).
  • A number between 0 and 3. You will see the number:
    • 0 (no receptors)
    • 1+ (a small number)
    • 2+ (a medium number)
    • 3+ (a large number of receptors)
  • The word "positive" or "negative."
wellness_dvd_promo

Email Updates

Stay informed about current research, online events, and more.

Please leave this field empty
Back to top

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

Learn more about our commitment to your privacy

© 2009 Breastcancer.org - All rights reserved.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.